Modulation of 5-Fu Pharmacology by Pala and Dipyridamole

Muss, Hyman B.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA056062-03
• Application #: 2097055
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Project Start: 1992-07-20
• Project End: 1996-09-30
• Budget Start: 1994-07-01
• Budget End: 1996-09-30
• Support Year: 3
• Fiscal Year: 1994

Institution

• Name: Wake Forest University Health Sciences
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 041418799
• City: Winston-Salem
• State: NC
• Country: United States
• Zip Code: 27106

Publications

Fleming, R A; Capizzi, R L; Muss, H B et al. (1996) Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer. Clin Cancer Res 2:1107-14